SPATA9 antibody
Principal name
SPATA9 antibody
Alternative names for SPATA9 antibody
Spermatogenesis-associated protein 9, NYD-SP16
Ncbi ID
9606, NP_114158, NM_031952, NP_114158.2, NP_083619.1, NM_029343
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection))
Background of SPATA9 antibody
- Kit Component:
- - KN208243G1, SPATA9 gRNA vector 1 in pCas-Guide vector
- KN208243G2, SPATA9 gRNA vector 2 in pCas-Guide vector
- KN208243D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Western Blot analysis of SPATA9 expression in transfected 293T cell line (H00083890-T01) by SPATA9 MaxPab polyclonal antibody.Lane 1: SPATA9 transfected lysate(27.94 KDa).Lane 2: Non-transfected lysate.
Human HepG2; WB Suggested Anti-SPATA9 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: HepG2 cell lysate; SPATA9 antibody - N-terminal region (ARP50024_P050) in Human HepG2 cells using Western Blot
WB Suggested Anti-SPATA9 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 312500; Positive Control: HepG2 cell lysate
WB Suggested Anti-SPATA9 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 12500; Positive Control: U937 cell lysate
Lysates
| Catalog No. | ||
|---|---|---|
| LY410397 | SPATA9 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR203215L2V | Lenti ORF particles, Spata9 (GFP-tagged) - Mouse spermatogenesis associated 9 (Spata9), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR203215L1V | Lenti ORF particles, Spata9 (Myc-DDK-tagged) - Mouse spermatogenesis associated 9 (Spata9), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
